Swiss Re introduces guidance for underwriters on repurposed longevity drugs

Share!

Reinsurance News - Aug 12, 2025

Swiss Re’s August 2025 Life Guide has introduced guidance for underwriters on how to assess life insurance applicants who show signs of using repurposed longevity drugs, an emerging trend among health-conscious individuals. The update provides new guidance on medications like metformin and rap...

Read Full Article

Recommended Articles

Berkshire Hathaway posts $2.4bn Q3’25 underwriting earnings amid strong P&C reinsurance result

Posted: Nov 01, 2025

Berkshire Hathaway, the Warren Buffett-run holding company and conglomerate, generated improved year...

AccuWeather estimates up to $52bn in economic losses from Hurricane Melissa

Posted: Oct 31, 2025

Hurricane Melissa, the first Cat 5 storm to make landfall in Jamaica’s history and among the stronge...

SCOR sees opportunities to grow in US cat at 1/1: Jean-Paul Conoscente

Posted: Oct 31, 2025

Jean-Paul Conoscente, Chief Executive Officer of SCOR P&C, said the French reinsurer views the U...